drugset / Trial / NCT01820299
Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is for subjects with solid cancers (gastrointestinal, lung, breast, prostate, lymphoma or cancer of the lymph nodes). The overall goal of this study is to identify plant-derived phytochemicals that can safely reduce systemic inflammation (inflammation throughout the entire body) in subjects with advanced cancer.
Timeline
- Start
- 2013-03
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Grape Seed Extract | Unknown | — | — |
| Subject | Vitamin D | Other / unclassified | 4000 iu | — |
Indications
No indication recorded.